Who is sponsoring NCT04829045?

NCT04829045 is sponsored by Universiti Putra Malaysia.

What drugs are being tested in NCT04829045?

Interventions in NCT04829045: SEIRIN PYONEX Acupuncture Needles, PYONEX Placebo.

What condition does NCT04829045 study?

NCT04829045 studies Diabetes Mellitus, Type 2, Acupuncture.

Is NCT04829045 still recruiting?

NCT04829045 is currently completed. Last updated 12 October 2023.

Last reviewed 2023-10-12 · How we verify

NCT04829045

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Acupuncture as Adjunctive Therapy in Patients With Type 2 Diabetes Mellitus

Completed NA Last updated 12 October 2023

What this trial tests

NA trial testing SEIRIN PYONEX Acupuncture Needles in Diabetes Mellitus, Type 2 in 46 participants. Completed in 31 December 2022.

Timeline

27 May 2021

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Universiti Putra Malaysia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	46
Start date	27 May 2021
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across Malaysia

Drugs / interventions tested

SEIRIN PYONEX Acupuncture Needles
PYONEX Placebo

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Acupuncture — all drugs for Acupuncture →

Sponsor

Universiti Putra Malaysia — full company profile →

Who can join

Adults 30 to 69, any sex, with Diabetes Mellitus, Type 2 or Acupuncture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine the effect of acupuncture as an adjunctive therapy on homeostasis model assessment-insulin resistance (HOMA-IR) and health-related quality of life (HRQoL) in patients with type 2 diabetes mellitus.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effectiveness of acupuncture as adjunctive therapy in type 2 diabetic: Study protocol for a randomized controlled trial.
Cheok YC, Mohd Shariff Z, Chan YM, Ng OC, et al · · 2023 · cited 3× · PMID 37729132 · DOI 10.1371/journal.pone.0284337
Effectiveness of Acupuncture as Adjunctive Therapy in Type 2 Diabetic: Study Protocol for a Randomized Controlled Trial
Cheok YC, Shariff ZM, Mun CY, Yein LP, et al · · 2022 · DOI 10.21203/rs.3.rs-718907/v1

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Universiti Putra Malaysia trials

Trials by the same sponsor.

NCT07365787 — Internet-Based Group CBT for Anxiety and Depression Among International Students · NA · not yet recruiting
NCT07325760 — Effectiveness of a ReMIND Diet Intervention on Sarcopenia, Cognitive Frailty and Nutritional Status in Older Adults · NA · not yet recruiting
NCT07139561 — A Digital Intervention to Improve Oral Health Practices · NA · not yet recruiting
NCT07095595 — The Effect of Education-based Patient Safety on Nursing Leaders' and Educators' Perceptions of Patient Safety Culture in · NA · active not recruiting
NCT07115433 — Effectiveness of School-based Oral Health Intervention for Children · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04829045 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universiti Putra Malaysia
Last refreshed: 12 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing